Activity-based kinase profiling of approved tyrosine kinase inhibitors
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activity-based kinase profiling of approved tyrosine kinase inhibitors
Authors
Keywords
-
Journal
GENES TO CELLS
Volume 18, Issue 2, Pages 110-122
Publisher
Wiley
Online
2012-12-27
DOI
10.1111/gtc.12022
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterization of kinase inhibitors using different phosphorylation states of colony stimulating factor-1 receptor tyrosine kinase
- (2011) D. Kitagawa et al. JOURNAL OF BIOCHEMISTRY
- Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes
- (2011) Thomas Force et al. NATURE REVIEWS DRUG DISCOVERY
- Expression of the vitamin K-dependent proteins GAS6 and protein S and the TAM receptor tyrosine kinases in human atherosclerotic carotid plaques
- (2011) Begoña Hurtado et al. THROMBOSIS AND HAEMOSTASIS
- SIK2 Is a Centrosome Kinase Required for Bipolar Mitotic Spindle Formation that Provides a Potential Target for Therapy in Ovarian Cancer
- (2010) Ahmed Ashour Ahmed et al. CANCER CELL
- Cardiac Myosin Light Chain Kinase Is Necessary for Myosin Regulatory Light Chain Phosphorylation and Cardiac Performancein Vivo
- (2010) Peiguo Ding et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cardiomyocyte PDGFR-β signaling is an essential component of the mouse cardiac response to load-induced stress
- (2010) Vishnu Chintalgattu et al. JOURNAL OF CLINICAL INVESTIGATION
- The cardiotoxicity and myocyte damage caused by small molecule anticancer tyrosine kinase inhibitors is correlated with lack of target specificity
- (2010) Brian B. Hasinoff TOXICOLOGY AND APPLIED PHARMACOLOGY
- Extended kinase profile and properties of the protein kinase inhibitor nilotinib
- (2009) Paul W. Manley et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- A Phase I and Pharmacokinetic Study of Oral Lapatinib Administered Once or Twice Daily in Patients with Solid Malignancies
- (2009) H. A. Burris et al. CLINICAL CANCER RESEARCH
- Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors
- (2009) G. D. Demetri et al. CLINICAL CANCER RESEARCH
- A Population Pharmacokinetic Meta-analysis of Sunitinib Malate (SU11248) and Its Primary Metabolite (SU12662) in Healthy Volunteers and Oncology Patients
- (2009) B. E. Houk et al. CLINICAL CANCER RESEARCH
- Phase I Trial of Pazopanib in Patients with Advanced Cancer
- (2009) H. I. Hurwitz et al. CLINICAL CANCER RESEARCH
- Determination of Human Serum α1-Acid Glycoprotein and Albumin Binding of Various Marketed and Preclinical Kinase Inhibitors
- (2009) Ferenc Zsila et al. CURRENT MEDICINAL CHEMISTRY
- Pazopanib
- (2009) Ronald M. Bukowski et al. NATURE REVIEWS DRUG DISCOVERY
- KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients
- (2009) K. S. Gajiwala et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Visualization of ATP levels inside single living cells with fluorescence resonance energy transfer-based genetically encoded indicators
- (2009) H. Imamura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerability
- (2008) N Widmer et al. BRITISH JOURNAL OF CANCER
- c-kit Is Required for Cardiomyocyte Terminal Differentiation
- (2008) Ming Li et al. CIRCULATION RESEARCH
- Nilotinib: a phenylamino-pyrimidine derivative with activity against BCR-ABL, KIT and PDGFR kinases
- (2008) Alfonso Quintás-Cardama et al. Future Oncology
- AMP Activated Protein Kinase-α2 Deficiency Exacerbates Pressure-Overload–Induced Left Ventricular Hypertrophy and Dysfunction in Mice
- (2008) Ping Zhang et al. HYPERTENSION
- Heterozygous disruption of Flk-1 receptor leads to myocardial ischaemia reperfusion injury in mice: application of affymetrix gene chip analysis
- (2008) M. Thirunavukkarasu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A quantitative analysis of kinase inhibitor selectivity
- (2008) Mazen W Karaman et al. NATURE BIOTECHNOLOGY
- FDA Drug Approval Summary: Lapatinib in Combination with Capecitabine for Previously Treated Metastatic Breast Cancer That Overexpresses HER-2
- (2008) Q. Ryan et al. ONCOLOGIST
- Protein purification and preliminary crystallographic analysis of human Lyn tyrosine kinase
- (2008) Takayoshi Kinoshita et al. PROTEIN EXPRESSION AND PURIFICATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation